NVS Novartis AG

Novartis's Treatment of ALS Granted FDA Orphan Designation

Novartis Pharmaceuticals' sotuletinib was granted FDA orphan designation as a treatment of Amyotrophic Lateral Sclerosis, according to a post to the agency's website.

12:00

CORDA Investment Management LLC. Has $16.42 Million Stake in Novartis AG (NYSE:NVS)

CORDA Investment Management LLC. raised its position in Novartis AG (NYSE:NVS – Get Rating) by 1.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange

01:21

People S United Financial Inc. Cuts Position in Novartis AG (NYSE:NVS)

People s United Financial Inc. lessened its holdings in Novartis AG (NYSE:NVS – Get Rating) by 3.7% during the first quarter, according to the company in its most recent disclosure with the SEC. The

08-16 23:52

Novartis' Treatment of Malaria Granted FDA Orphan Designation

Novartis Pharmaceuticals' ganaplacide and lumefantrine fixed-dose combination was granted FDA orphan designation as a treatment of malaria, according to a post to the agency's website.

08-16 00:10

A Look Into Healthcare Sector Value Stocks

  Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base in

08-15 22:45

Novartis canakinumab fails another phase 3 study in lung cancer

Novartis (NYSE:NVS) said its medicine canakinumab (ACZ885) did not meet the main goal of disease-free survival (DFS) versus placebo in a phase 3 trial in patients with a type of lung cancer. The study

08-15 16:40

Novartis Phase 3 Canopy-A Trial Didn't Meet Primary Endpoint

By Kim Richters Novartis AG's Phase 3 Canopy-A study for canakinumab as adjuvant treatment in non-small cell lung cancer didn't meet the primary endpoint of disease-free survival versus placebo. The

08-15 13:35

Novartis AG (NYSE:NVS) Shares Acquired by Morningstar Investment Services LLC

Morningstar Investment Services LLC boosted its stake in Novartis AG (NYSE:NVS – Get Rating) by 0.2% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 429,087 shar

08-14 01:01

Level Four Advisory Services LLC Purchases 5,103 Shares of Novartis AG (NYSE:NVS)

Level Four Advisory Services LLC lifted its position in Novartis AG (NYSE:NVS – Get Rating) by 60.3% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The inst

08-13 22:51

The Most Expensive Drug From Novartis Associated With Two Deaths: Report

Two children with spinal muscular atrophy have died after receiving Novartis AG's (NYSE:NVS) Zolgensma, a one-time gene therapy, spotlighting its risks and questioning the safety of genetic medicines

08-12 23:15